Expression of CD38 on Macrophages Predicts Improved Prognosis in Hepatocellular Carcinoma

Frontiers in Immunology - Switzerland
doi 10.3389/fimmu.2019.02093
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Decreased DC‑SIGNR Expression in Hepatocellular Carcinoma Predicts Poor Patient Prognosis

Oncology Letters
Cancer ResearchOncology
2019English

Co-Expression of LASS2 and TGF-β1 Predicts Poor Prognosis in Hepatocellular Carcinoma

Scientific Reports
Multidisciplinary
2016English

Increased Programmed Death Ligand-1 Expression Predicts Poor Prognosis in Hepatocellular Carcinoma Patients

OncoTargets and Therapy
OncologyPharmacology
2016English

High Expression of Thymosin Beta 10 Predicts Poor Prognosis for Hepatocellular Carcinoma After Hepatectomy

World Journal of Surgical Oncology
SurgeryOncology
2014English

Downregulation of Serum Exosomal miR‐320d Predicts Poor Prognosis in Hepatocellular Carcinoma

Journal of Clinical Laboratory Analysis
AllergyImmunologyBiochemistryPublic HealthMedical Laboratory TechnologyClinical BiochemistryHematologyMicrobiologyEnvironmentalOccupational Health
2020English

The Upregulation of Trophinin-Associated Protein (TROAP) Predicts a Poor Prognosis in Hepatocellular Carcinoma

Journal of Cancer
Oncology
2019English

PDCD5 Expression Predicts a Favorable Outcome in Patients With Hepatocellular Carcinoma

International Journal of Oncology
Cancer ResearchOncology
2013English

Over-Expression of Cathepsin B in Hepatocellular Carcinomas Predicts Poor Prognosis of HCC Patients

Molecular Cancer
Cancer ResearchOncologyMolecular Medicine
2016English

Overexpression of XIAP Expression in Renal Cell Carcinoma Predicts a Worse Prognosis

International Journal of Oncology
Cancer ResearchOncology
2007English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy